Fibroblast growth factor 13 is a protein that in humans is encoded by the FGF13gene.
The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. This gene is located to a region associated with Borjeson-Forssman-Lehmann syndrome (BFLS), a syndromal X-linked mental retardation, which suggests it may be a candidate gene for familial cases of the BFL syndrome. The function of this gene has not yet been determined. Two alternatively spliced transcripts encoding different isoforms have been described for this gene.
Wittmack EK, Rush AM, Craner MJ et al. (2005). "Fibroblast growth factor homologous factor 2B: association with Nav1.6 and selective colocalization at nodes of Ranvier of dorsal root axons.". J. Neurosci.24 (30): 6765–75. doi:10.1523/JNEUROSCI.1628-04.2004. PMID15282281.CS1 maint: Explicit use of et al. (link)
Popovici C, Conchonaud F, Birnbaum D, Roubin R (2004). "Functional phylogeny relates LET-756 to fibroblast growth factor 9.". J. Biol. Chem.279 (38): 40146–52. doi:10.1074/jbc.M405795200. PMID15199049.
Facchiano A, Russo K, Facchiano AM et al. (2003). "Identification of a novel domain of fibroblast growth factor 2 controlling its angiogenic properties.". J. Biol. Chem.278 (10): 8751–60. doi:10.1074/jbc.M209936200. PMID12496262.CS1 maint: Explicit use of et al. (link)
Schoorlemmer J, Goldfarb M (2003). "Fibroblast growth factor homologous factors and the islet brain-2 scaffold protein regulate activation of a stress-activated protein kinase.". J. Biol. Chem.277 (51): 49111–9. doi:10.1074/jbc.M205520200. PMID12244047.
Knox S, Merry C, Stringer S et al. (2002). "Not all perlecans are created equal: interactions with fibroblast growth factor (FGF) 2 and FGF receptors.". J. Biol. Chem.277 (17): 14657–65. doi:10.1074/jbc.M111826200. PMID11847221.CS1 maint: Explicit use of et al. (link)
Munoz-Sanjuan I, Smallwood PM, Nathans J (2000). "Isoform diversity among fibroblast growth factor homologous factors is generated by alternative promoter usage and differential splicing.". J. Biol. Chem.275 (4): 2589–97. doi:10.1074/jbc.275.4.2589. PMID10644718.
Gecz J, Baker E, Donnelly A et al. (1999). "Fibroblast growth factor homologous factor 2 (FHF2): gene structure, expression and mapping to the Börjeson-Forssman-Lehmann syndrome region in Xq26 delineated by a duplication breakpoint in a BFLS-like patient.". Hum. Genet.104 (1): 56–63. doi:10.1007/s004390050910. PMID10071193.CS1 maint: Explicit use of et al. (link)
Yao DL, Masonic K, Petullo D et al. (1999). "Pretreatment with intravenous FGF-13 reduces infarct volume and ameliorates neurological deficits following focal cerebral ischemia in rats.". Brain Res.818 (1): 140–6. doi:10.1016/S0006-8993(98)01118-4. PMID9914447.CS1 maint: Explicit use of et al. (link)
Greene JM, Li YL, Yourey PA et al. (1998). "Identification and characterization of a novel member of the fibroblast growth factor family.". Eur. J. Neurosci.10 (5): 1911–25. doi:10.1046/j.1460-9568.1998.00211.x. PMID9751161.CS1 maint: Explicit use of et al. (link)